Biogen (BIIB) options active after speculation in Korean press
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Yearly Drug Price Changes by Biogen (BIIB), Gilead (GILD), Regeneron (REGN) and Vertex (VRTX) - Truist
January 3, 2022 5:39 AM ESTTruist analyst Robyn Karnauskas recaps recently announced drug price changes by Biogen (NASDAQ: BIIB), Regeneron (NASDAQ: REGN), Vertex Pharma (NASDAQ: VRTX), and Gilead Sciences (NASDAQ:... More



